Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial

Original research
by
Nuijten, Mascha et al

Release Date

2016

Geography

Netherlands

Language of Resource

English

Full Text Available

Yes

Open Access / OK to Reproduce

No

Peer Reviewed

Yes

Objective

Heroin-assisted treatment is eff ective for methadone treatment-refractory heroin-dependent patients, but continued comorbid cocaine dependence remains problematic. Sustained-release dexamfetamine is a promising agonist pharmacotherapy for cocaine dependence and we aimed to assess its acceptance, effi cacy, and safety.

Findings/Key points

Sustained-release dexamfetamine is a well accepted, eff ective, and safe agonist pharmacotherapy for comorbid treatment-refractory cocaine dependence in heroin-dependent patients in heroin-assisted treatment.

Design/methods

Double-blind placebo-controlled RCT, n=73

Keywords

Safer supply
About PWUD
Outcomes
Illegal drugs
Stimulants